Aspirin and Dipyridamole Capsules and Lanreotide Subcutaneous
Determining the interaction of Aspirin and Dipyridamole Capsules and Lanreotide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: aspirin / dipyridamole
Brand name: Aggrenox
Synonyms: Aspirin and dipyridamole, Aspirin and Dipyridamole
Generic Name: lanreotide
Brand name: Somatuline Depot
Synonyms: Lanreotide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Aspirin and Dipyridamole Capsules-Lansoprazole
- Aspirin and Dipyridamole Capsules-Lansoprazole Delayed-Release Capsules
- Aspirin and Dipyridamole Capsules-Lansoprazole Orally Disintegrating Tablets
- Aspirin and Dipyridamole Capsules-Lansoprazole, Amoxicillin, and Clarithromycin
- Aspirin and Dipyridamole Capsules-Lanthanum
- Aspirin and Dipyridamole Capsules-Lanthanum carbonate
- Lanreotide Subcutaneous-Aspirin and omeprazole
- Lanreotide Subcutaneous-Aspirin and Omeprazole Tablets
- Lanreotide Subcutaneous-Aspirin and oxycodone
- Lanreotide Subcutaneous-Aspirin Chewable Tablets
- Lanreotide Subcutaneous-Aspirin Enteric-Coated and Buffered Tablets
- Lanreotide Subcutaneous-Aspirin Extended-Release Capsules